Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 29 | 29 | 30 | 29 | 230 |
| Operating Expenses | 36,370 | 27,110 | 25,299 | 20,929 | 24,241 |
| Operating Income | -36,341 | -27,081 | -25,269 | -20,900 | -24,011 |
| Interest Expense | 101 | 78 | 25 | 9 | 9 |
| Other Income | 2,343 | -2,345 | 8,524 | -55,481 | 5,008 |
| Pre-tax Income | -34,099 | -29,504 | -16,770 | -76,390 | -19,012 |
| Income Tax | -35 | 22 | -236 | 90 | 25 |
| Net Income Continuous | -34,064 | -29,526 | -16,534 | -76,480 | -19,037 |
| Net Income | $-34,064 | $-29,526 | $-16,534 | $-76,480 | $-19,037 |
| EPS Basic Total Ops | -0.28 | -0.24 | -0.15 | -0.78 | -0.21 |
| EPS Basic Continuous Ops | -0.28 | -0.24 | -0.15 | -0.78 | -0.21 |
| EPS Diluted Total Ops | -0.28 | -0.24 | -0.15 | -0.78 | -0.21 |
| EPS Diluted Continuous Ops | -0.28 | -0.24 | -0.15 | -0.78 | -0.21 |
| EBITDA(a) | $-33,496 | $-28,933 | $-16,342 | $-75,990 | $-18,614 |